The antinuclear antibody test, often shortened to ANA, analyses a blood sample to look for certain antibodies called antinuclear antibodies. To explain briefly, the immune system produces protective antibodies to fight infections. But in some cases, these antibodies get confused and misdirected and can start targeting the body's own normal healthy tissues and organs instead of defending them from external disease-causing microbes or foreign substances. These types of faulty attacking antibodies are termed as autoantibodies.
The ANA profile test is able to detect a variety of these autoantibodies that can identify components present inside the command centre of the body's cells as foreign. This command centre known as the nucleus holds the cell's DNA or genetic material and manages vital cell functions. If ANA test levels are significantly high, it can trigger the body's immune sentinels to launch assaults on its own organs and tissues, resulting in self-damage and autoimmune illnesses over time.
The full form of ANA is an antinuclear antibody. It is a blood investigation used to look for anti-nuclear antibodies or ANAs. To simplify - ANAs are a class of autoantibodies produced by a person's own immune machinery. Instead of guarding the body's tissues from external disease-creating microorganisms as antibodies normally should, these ANAs mistake normal internal body components as foreign and target them.
Specifically, ANAs can attack structures inside the nucleus of cells which contain the cellular DNA. The nucleus is the control centre of each cell, which decides how the cell functions. When ANA levels rise significantly high, they can activate the body's immune defences to start attacking its own cells and tissues. This gradual self-attack eventually causes inflammation and organ damage over time, leading to characteristic symptoms of autoimmune disorders.
Although an ANA test cannot confirm a specific diagnosis, it may help exclude some autoimmune diseases. It is typically applied when a physician suspects an autoimmune disease such as lupus, rheumatoid arthritis or scleroderma based on the patient’s clincal manifestation.
If the ANA test is positive, the blood can also be tested for certain ANAs that are known to involve specific diseases. This adds more details to identify the possible cause of the symptoms.
An ANA test may be ordered if a person has symptoms suggestive of an autoimmune disorder, such as:
When a physician orders the antinuclear antibodies test for a patient, the only specimen required is a blood sample. This sample is typically collected from the vein in the patient's arm.
To draw the blood, first the area of skin over the vein is cleaned and disinfected thoroughly. Then a tight band is wrapped around the upper arm to cause the veins below to swell up. This makes the veins more visible and prominent for the phlebotomist to easily insert the needle connected to the collection tubes into the vein.
The actual blood sample collection takes less than 5 minutes in most cases. Once adequate blood is withdrawn into the tubes, the needle is removed instantly and a cotton swab is pressed on the area to prevent excessive bleeding or bruising. The patient can resume normal activities right after sample collection.
Subsequently, the blood sample tubes are appropriately labelled and transported in controlled conditions to the diagnostics laboratory. Here, trained professionals analyse the sample to determine the levels of antinuclear antibodies.
Some key diagnostic and monitoring uses of the ANA test include:
Thus, when interpreted carefully in correlation with clinical presentation, ANA testing provides valuable diagnostic clues regarding one’s autoimmune status.
The most commonly performed laboratory technique for ANA detection is called the indirect immunofluorescence assay (IFA). Steps include:
Thus, IFA allows sensitive visualisation and detection of antibodies directed against multiple nuclear components.
Patients do not need any specific preparation for undergoing the antinuclear antibodies examination. One can continue normal diet and fluid intake routines prior to the test without any restrictions.
However, it is advisable to consult the healthcare provider regarding current medications and supplements. Certain prescription drugs, over-the-counter pills or herbal remedies can potentially impact the accuracy of the test.
ANA test reports provide an interpretation (positive/negative), a titer reading indicating the amount of ANAs, and the fluorescent pattern seen.
A positive ANA does not always mean autoimmune disease. Many healthy individuals have low-positive ANAs. Also some infections and drugs can cause ANAs. Along with ANA results, doctors consider symptoms, exam findings and other test results to make a diagnosis.
A positive ANA test with a high titer may indicate:
Negative ANA makes autoimmune disease unlikely, but does not completely rule it out in presence of strong clinical suspicion.
Positive ANA with low titer may be seen in:
In these cases, other clinical information is considered before making treatment decisions.
The ANA test is an important screening tool that detects antibodies which may be attacking the body's own tissues. However, positive ANA tests also occur in healthy people and certain medical conditions.
Thus, ANA tests must be interpreted carefully in the context of the patient's symptoms and other clinical information. A detailed evaluation is needed to make an accurate autoimmune diagnosis for patients with positive ANA. Treatment is tailored accordingly.
ANA test normal range is less than 1:40. Up to 20% of healthy people can have weakly positive ANAs.
If the ANA test is positive, additional tests are carried out to determine if there are specific autoantibodies causing particular diseases. Presence of related symptoms/conditions also provides diagnostic clues.
A negative ANA makes autoimmune diseases unlikely but further evaluation may be needed if symptoms strongly suggest it. Other mimicking conditions are then explored.
The actual blood draw process takes less than 5 minutes. However, the test analysis in the laboratory may require anywhere between 1 to 10 days for the final report to be ready.
Yes, joint pain and inflammation can occur as part of the clinical picture in ANA-linked autoimmune conditions such as lupus and rheumatoid arthritis. This happens due to immune-mediated inflammation spreading to joint tissues and causing damage over time.
The treatment approach for a patient with a positive ANA test involves tailored therapy based on the suspected or confirmed underlying autoimmune illness. It requires close guidance of a specialised rheumatologist.